A paper in the Journal of the National Cancer Institute finds that almost 20% of patients in middle-stage cancer drug trials ...

It’s a $4 billion a year industry that includes fraudulent anti-cancer drugs and opioid medications. Here is what patients ...

Bristol Myers said about 5% to 7% of people with metastatic colorectal cancer have microsatellite instability-high or mismatch-repair-deficient tumors, adding that these patients are less likely to ...